FMC Corp: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 2, 2017 and accepted by EDGAR at Aug 2, 2017, 20:21 ET.
Management's discussion and analysis
As filed, 60,944 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.
Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expect”, “expects”, “should”, “could”, “may”, “will continue to”, “believe”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2016 (the “2016 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.
We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2016 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.
The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2016 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.
- Revenue recognition and trade receivables
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets and indefinite-lived assets
- Pensions and other postretirement benefits
- Income taxes
RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS
See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.
OVERVIEW
We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in two distinct business segments: FMC Agricultural Solutions and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis application.
Second Quarter 2017 Highlights
The following are the more significant developments in our businesses during the three months ended June 30, 2017:
- Revenue of $656.8 million for the three months ended June 30, 2017 increased $41.5 million or 7 percent versus the same period last year. The increase in revenue was attributable to both FMC Agricultural Solutions and FMC Lithium. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America decreased 5 percent period over period while sales in Asia increased by 6 percent, sales in Latin America increased 37 percent, and sales in Europe, Middle East and Africa increased by 5 percent.
- Our gross margin of $234.4 million decreased slightly versus the prior year's second quarter by $1.0 million. Gross margin percent of 36 percent also decreased compared to 38 percent in the prior year.
- Selling, general and administrative expenses, excluding acquisition-related charges and non-operating pension and postretirement charges, increased by approximately $5 million or 5 percent to $109.8 million.
- Research and development expenses of $32.0 million decreased $1.2 million or 4 percent. A majority of the decrease was due to registration and regulatory timing within FMC Agricultural Solutions.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $64.8 million increased compared to the prior year amount of $62.3 million primarily due to higher results in FMC Lithium, which were partially offset by decreases in FMC Agricultural Solutions. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
Other Highlights
In June 2017, we signed a definitive agreement to sell the Omega-3 business to Pelagia AS. Refer to Note 10.
In May 2017, we entered into a new $1.5 billion term loan facility to fund the Transaction Agreement with DuPont.We also entered into an amended and restated $1.5 billion revolving credit facility and amended the existing term loan facility at that time. Among other things, the amendments temporarily increased the maximum leverage ratio financial covenant in order to permit the debt incurred under the contemplated New Term Loan Facility along with certain other changes to permit the expected transaction.
RESULTS OF OPERATIONS
Overview
The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income (charges).
SEGMENT RESULTS RECONCILIATION
(in Millions)
| 2017 Revenue | Three Months Ended June 30 | 2016 | Six Months Ended June 30 2017 | 2016 |
|---|---|---|---|---|
| FMC Agricultural Solutions | $582.8 | $552.0 | $1,113.2 | $1,098.1 |
| FMC Lithium | 74.0 | 63.3 | 139.6 | 123.6 |
| Total revenue | $656.8 | $615.3 | $1,252.8 | $1,221.7 |
| Income from continuing operations before income taxes | ||||
| FMC Agricultural Solutions | $95.7 | $100.7 | $178.7 | $182.7 |
| FMC Lithium | 24.2 | 16.5 | 45.8 | 31.4 |
| Segment operating profit (1) | $119.9 | $117.2 | $224.5 | $214.1 |
| Corporate and other | (27.2) | (19.4) | (48.8) | (36.1) |
| Operating profit before the items listed below | $92.7 | $97.8 | $175.7 | $178.0 |
| Interest expense, net | (17.2) | (15.2) | (32.9) | (31.0) |
| Corporate special (charges) income: | ||||
| Restructuring and other (charges) income (2) | (6.9) | (9.1) | (15.2) | (18.6) |
| Non-operating pension and postretirement charges (3) | 4.1 | (1.2) | 8.7 | (2.3) |
| Acquisition-related charges (4) | (20.7) | (5.0) | (29.9) | (12.4) |
| (Provision) benefit for income taxes | (3.3) | (20.5) | (12.7) | (40.9) |
| Discontinued operations, net of income taxes | 26.6 | 20.2 | (142.2) | 42.9 |
| Net income attributable to noncontrolling interests | (0.6) | (1.8) | (1.0) | (2.2) |
| Net income (loss) attributable to FMC stockholders | $74.7 | $65.2 | $(49.5) | $113.5 |
(1) Referred to as Segment Earnings.
(2) See Note 8 for details of restructuring and other (charges) income. Below provides the detail the (charges) income by segment:
(in Millions)
| Three Months Ended June 30 2017 | 2016 | Six Months Ended June 30 2017 | 2016 | |
|---|---|---|---|---|
| FMC Agricultural Solutions | $(0.2) | $(5.9) | $(4.7) | $(12.5) |
| FMC Lithium | — | — | — | (0.6) |
| Corporate | (6.7) | (3.2) | (10.5) | (5.5) |
| Restructuring and other (charges) income | $(6.9) | $(9.1) | $(15.2) | $(18.6) |
(3) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).
(4) Charges relate to the expensing of the integration related legal and professional third-party fees associated with the planned or completed acquisitions. Amounts represent the following:
(in Millions)
| Acquisition-related charges - DuPont | Three Months Ended June 30 2017 | 2016 | Six Months Ended June 30 2017 | 2016 |
|---|---|---|---|---|
| Legal and professional fees (1) | $20.7 | $— | $29.9 | $— |
| Acquisition-related charges - Cheminova (2) | ||||
| Legal and professional fees (1) | $— | $5.0 | $— | $12.4 |
| Total Acquisition-related charges | $20.7 | $5.0 | $29.9 | $12.4 |
(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information see Note 3.
(2) Acquisition-related charges to integrate Cheminova with FMC Agricultural Solutions were completed at the end of 2016.
The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income (loss) attributable to FMC stockholders.” We believe that this measure provides useful information about our operating results to investors. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.
ADJUSTED EARNINGS RECONCILIATION
(in Millions)
| 2017 | Three Months Ended June 30 | 2016 | Six Months Ended June 30 2017 | 2016 |
|---|---|---|---|---|
| Net income (loss) attributable to FMC stockholders (GAAP) | $74.7 | $65.2 | $(49.5) | $113.5 |
| Corporate special charges (income), pre-tax | 23.5 | 15.3 | 36.4 | 33.3 |
| Income tax expense (benefit) on Corporate special charges (income) (1) | (8.1) | (4.5) | (12.5) | (9.7) |
| Corporate special charges (income), net of income taxes | $15.4 | $10.8 | $23.9 | $23.6 |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | (26.5) | (20.2) | 142.2 | (42.9) |
| Non-GAAP tax adjustments (2) | 1.2 | 6.5 | 6.6 | 16.1 |
| Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP) | $64.8 | $62.3 | $123.2 | $110.3 |
(1) The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the Corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the Non-GAAP performance measure.
(2) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.
In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.
Segment Results
For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition-related charges, and other income and expense items.
Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 18 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2016 Form 10-K.
FMC Agricultural Solutions
(in Millions)
| 2017 | Three Months Ended June 30 | 2016 | Six Months Ended June 30 2017 | 2016 |
|---|---|---|---|---|
| Revenue | $582.8 | $552.0 | $1,113.2 | $1,098.1 |
| Operating Profit | 95.7 | 100.7 | 178.7 | 182.7 |
Revenue
Three months ended June 30, 2017 vs. 2016
Revenue of $582.8 million increased approximately 6 percent versus the prior year quarter primarily due to overall higher sales mainly from higher volumes in Latin America. Overall, higher volumes increased revenue by 10 percent compared to the prior period while pricing had a 4 percent negative impact. See below for discussion on revenue by region.
Six months ended June 30, 2017 vs. 2016
Revenue of $1,113.2 million increased approximately 1 percent versus the prior year period primarily due to higher volumes discussed for the three months ended June 30, 2017 above, which more than offset lower volumes from the first quarter of 2017. The higher volumes increased revenue by 3 percent period over period while pricing and mix had a 2 percent negative impact. See below for discussion on revenue by region.
FMC Agricultural Solutions Combined Revenue by Region
(in Millions)
| Three Months Ended June 30 2017 | 2016 | Six Months Ended June 30 2017 | 2016 | |
|---|---|---|---|---|
| Europe, Middle East and Africa (EMEA) (1) | $166.9 | $162.2 | $343.7 | $367.5 |
| North America (2) | 171.8 | 185.6 | 323.9 | 335.6 |
| Latin America (3) | 128.1 | 93.1 | 223.0 | 194.1 |
| Asia (4) | 116.0 | 111.1 | 222.6 | 200.9 |
| Total FMC Agricultural Solutions Revenue | $582.8 | $552.0 | $1,113.2 | $1,098.1 |
(1) Increase in the three months ended June 30, 2017 was due to favorable pricing and new product launches. These increases were somewhat offset by lower fungicides volume and hot, dry conditions in Southern Europe. The decrease in the six months ended June 30, 2017 was primarily due to the late start to the season in Northwestern Europe in the three months ended March 31, 2017, partially offset by the favorable pricing and new product launches in cereal herbicides and fungicides in the three months ended June 30, 2017.
(2) Decrease in the three months ended June 30, 2017 was due to lower volumes and price in the region. The lower volume impacted herbicides for rice and insecticides for corn. The decrease in the six months ended June 30, 2017 was primarily due to the same reasons mentioned in the three months ended June 30, 2017.
(3) Increase in the three months ended June 30, 2017 was primarily driven by higher volumes in Brazil, due to the increased cotton production and yields, as well as increased volumes of pre-emergent herbicides in Argentina. The increase in the six months ended June 30, 2017 was due to the favorable volume impacts discussed above as well as favorable foreign currency impacts in Brazil.
(4) Increase for both the three and six months ended June 30, 2017 was primarily due to successful product launches in China for the three and six months ended June 30, 2017. Additionally, there were increased herbicide volumes in Australia from pasture application as well as increased demand for rice insecticides in Indonesia.
Operating Profit
Three months ended June 30, 2017 vs. 2016
FMC Agricultural Solutions' operating profit of $95.7 million decreased by approximately 5 percent compared to the year-ago quarter. The decrease was mainly driven by unfavorable price which contributed 21 percent to the decline. This was offset by increases in volumes and foreign currency which contributed 14 percent and 3 percent, respectively. Additionally, higher costs had a 1 percent negative impact on profit.
Six months ended June 30, 2017 vs. 2016
Operating profit of $178.7 million decreased approximately 2 percent versus the prior year period. The decrease was mainly driven by unfavorable price and product mix which contributed 9 percent to the decline. This was offset by increases in volumes and foreign currency which contributed 3 percent and 4 percent, respectively.
Outlook
For 2017, full-year segment revenue is expected to be approximately $2.3 billion to $2.4 billion and full-year segment earnings are expected to be in the range of $415 million to $445 million. The outlook excludes any earnings from the pending transaction with DuPont which is expected to close in the fourth quarter of 2017.
FMC Lithium
(in Millions)
| 2017 | Three Months Ended June 30 | 2016 | Six Months Ended June 30 2017 | 2016 |
|---|---|---|---|---|
| Revenue | $74.0 | $63.3 | $139.6 | $123.6 |
| Operating Profit | 24.2 | 16.5 | 45.8 | 31.4 |
Three months ended June 30, 2017 vs. 2016
Revenue of $74.0 million increased by approximately 17 percent versus the prior-year quarter. Higher pricing contributed 20 percent to the revenue increase while lower volumes impacted revenue by 2 percent. The lower volumes were caused by an increase in work in process material as carbonate was shipped to supply the new hydroxide plant. Unfavorable foreign currency had a minimal impact of 1 percent on revenue.
Segment operating profit of $24.2 million increased $7.7 million versus the year ago quarter. The favorable pricing noted above impacted results by approximately $12 million. Favorable foreign currency impacts increased operating profit by less than $1 million. These increases were offset by higher operating costs, which impacted results by approximately $4 million driven by costs related to expansion. The lower volumes noted above reduced operating profit by approximately $1 million.
Six months ended June 30, 2017 vs. 2016
Revenue of $139.6 million increased by approximately 13 percent versus the prior-year period. Higher pricing contributed 19 percent to the revenue increase while lower volumes impacted revenue by 6 percent. The lower volumes were caused by an increase in work in process material due to some shifts in carbonate to supply the new hydroxide plant.
Segment operating profit of $45.8 million increased $14.4 million versus the prior-year period. The favorable pricing noted above impacted results by approximately $24 million. Favorable foreign currency impacts increased operating profit by approximately $1 million. These increases were offset by higher operating costs, which impacted results by approximately $7 million driven by higher raw material and energy prices as well as expansion related costs. The lower volumes noted above reduced operating profit by $4 million.
Outlook
Segment earnings are now expected to be between $115 million and $125 million for the full year of 2017, an increase of 71 percent over 2016 at the mid-point of the range and $10 million higher than the previous range.
We continue to invest in FMC Lithium and to move forward with our plans to expand our lithium hydroxide operations. We will continue to operate FMC Lithium as a standalone business within FMC. Our strategic intent is that we will spin off FMC Lithium as a separate, publicly traded company.
Other Results of Operations
Corporate and other
Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).
Three months ended June 30, 2017 vs. 2016
Corporate and other expenses of $27.2 million in the second quarter of 2017 increased by $7.8 million from $19.4 million in the same period in 2016. The increase was primarily driven by approximately $4 million of foreign exchange losses associated with intercompany loans. Additionally, the prior period included approximately $2 million of LIFO income that did not recur in 2017.
Six months ended June 30, 2017 vs. 2016
Corporate and other expenses of $48.8 million in the first half of 2017 increased by $12.7 million from $36.1 million in the same period in 2016. The increase was primarily driven by approximately $5 million of foreign exchange losses associated with intercompany loans and approximately $3 million of higher corporate facility costs. The LIFO impact discussed above also impacted the six months ended results.
Interest expense, net
Three months ended June 30, 2017 vs. 2016
Interest expense, net for the second quarter of 2017 of $17.2 million increased primarily due to higher foreign debt balances and increases in interest rates and partially offset by lower term loan balances as compared to the second quarter of 2016 of $15.2 million.
Six months ended June 30, 2017 vs. 2016
Interest expense, net for the first half of 2017 of $32.9 million increased primarily due to higher foreign debt balances and increases in interest rates and partially offset by lower term loan balances as compared to the first half of 2016 of $31.0 million.
Corporate special charges (income)
Restructuring and other charges (income)
(in Millions)
| Three Months Ended June 30 2017 | 2016 | Six Months Ended June 30 2017 | 2016 | |
|---|---|---|---|---|
| Restructuring charges and asset disposals | $2.7 | $5.9 | $2.7 | $8.9 |
| Other charges (income), net | 4.2 | 3.2 | 12.5 | 9.7 |
| Total restructuring and other charges (income) | $6.9 | $9.1 | $15.2 | $18.6 |
Three months ended June 30, 2017 vs. 2016
Restructuring and asset disposal charges in 2017 of $2.7 million were primarily related to the other Corporate charges.
Restructuring and asset disposal charges in 2016 of $5.9 million were primarily associated with the Cheminova restructuring to integrate the business into our existing FMC Agricultural Solutions segment for the quarter.
Other charges (income), net in 2017 of $4.2 million were primarily related to $3.3 million of environmental related charges as well as $0.9 million of other miscellaneous charges.
Other charges (income), net in 2016 of $3.2 million were primarily related to $2.5 million of environmental related charges. Additionally, we had other miscellaneous charges of $0.7 million.
The liabilities associated with the restructuring charges listed above are also included within Note 8 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.
Non-operating pension and postretirement charges
The income for the three months ended June 30, 2017 was $4.1 million compared to a charge of $1.2 million for the three months ended June 30, 2016. The decrease in charges was primarily due to the change in estimate of amortizing gains and losses over the expected lifetime of the inactive population rather than the average remaining service period of active participants as described in our 2016 Form 10-K. The gain/loss amortization period for the U.S. qualified pension plan increased from about eight years to about nineteen years as a result of this change. See Note 14 to the condensed consolidated financial statements included in this
Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).
Acquisition-related charges
A detailed description of the acquisition-related charges is included in Note 18 to the condensed consolidated financial statements included within this Form 10-Q.
Six months ended June 30, 2017 vs. 2016
Restructuring and asset disposal charges in 2017 of $2.7 million were primarily related to the other Corporate charges.
Restructuring and asset disposal charges in 2016 of $8.9 million were primarily associated with the Cheminova restructuring to integrate the business into our existing FMC Agricultural Solutions segment for the quarter.
Other charges (income), net in 2017 of $12.5 million were primarily related to $5.6 million of environmental related charges. Other charges (income), net also included $4.7 million of exit costs resulting from the termination and deconsolidation of a variable interest entity that was previously consolidated and was part of our FMC Agricultural Solutions segment. Additionally, we had $2.2 million of charges related to Corporate. See Note 8 within the condensed consolidated financial statements included in this Form 10-Q for more information.
Other charges (income), net in 2016 of $9.7 million were primarily related to $9.1 million of environmental related charges as well as $4.2 million of charges associated with currency devaluation within Argentina as a result of deliberate actions by the government of that country. These charges were offset by other miscellaneous income of $3.6 million.
Non-operating pension and postretirement charges
The income for the six months ended June 30, 2017 was $8.7 million compared to a charge of $2.3 million for the six months ended June 30, 2016. The decrease in charges was primarily due to the change in estimate of amortizing gains and losses over the expected lifetime of the inactive population rather than the average remaining service period of active participants as described in our 2016 Form 10-K.
Acquisition-related charges
A detailed description of the acquisition-related charges is included in Note 18 to the condensed consolidated financial statements included within this Form 10-Q.
Provision for income taxes
A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Denmark and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States taxes have not been previously accrued.
Three months ended June 30, 2017 vs. 2016
Provision for income taxes for the three months ended June 30, 2017 was $3.3 million resulting in an effective tax rate of 6.3 percent and was $20.5 million resulting in an effective tax rate of 30.5 percent for the three months ended June 30, 2016. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 15 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.
(in Millions)
| Three Months Ended June 30 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2016 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | |
|---|---|---|---|---|---|---|
| GAAP - Continuing operations | $52.0 | $3.3 | 6.3% | $67.3 | $20.5 | 30.5% |
| Corporate special charges | 23.5 | 8.1 | 15.3 | 4.5 | ||
| Tax adjustments (1) | (1.2) | (6.5) | ||||
| Non-GAAP - Continuing operations | $75.5 | $10.2 | 13.5% | $82.6 | $18.5 | 22.4% |
(1) Refer to note 2 of the Adjusted Earnings Reconciliation of this Form 10-Q for an explanation of tax adjustments.
The primary drivers for the decrease in the second quarter effective tax rate for 2017 compared to 2016 are shown in the table above. The remaining change was due to reduced domestic earnings in our FMC Agricultural Solutions business and the impact of the full integration of Cheminova into our global supply chain.
Six months ended June 30, 2017 vs. 2016
Provision for income taxes for the six months ended June 30, 2017 was $12.7 million resulting in an effective tax rate of 11.9 percent and was $40.9 million resulting in an effective tax rate of 36 percent for the six months ended June 30, 2016. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 15 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.
(in Millions)
| Six Months Ended June 30 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2016 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | |
|---|---|---|---|---|---|---|
| GAAP - Continuing operations | $106.4 | $12.7 | 11.9% | $113.7 | $40.9 | 36.0% |
| Corporate special charges | 36.4 | 12.5 | 33.3 | 9.7 | ||
| Tax adjustments (1) | (6.6) | (16.1) | ||||
| Non-GAAP - Continuing operations | $142.8 | $18.6 | 13.0% | $147.0 | $34.5 | 23.5% |
(1) Refer to note 2 of the Adjusted Earnings Reconciliation of this Form 10-Q for an explanation of tax adjustments.
The primary drivers for the decrease in the year-to-date effective tax rate for 2017 compared to 2016 are shown in the table above. The remaining change was due to reduced domestic earnings in our FMC Agricultural Solutions business and the impact of the full integration of Cheminova into our global supply chain.
Discontinued operations, net of income taxes
Our discontinued operations represent our discontinued FMC Health and Nutrition as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Three months ended June 30, 2017 vs. 2016
Discontinued operations, net of income taxes represented a gain of $26.6 million for the three months ended June 30, 2017, compared to $20.2 million for the three months ended June 30, 2016. The results for the three months ended June 30, 2017 include a $13.8 million ($13.8 million, net of tax) adjustment to the impairment charge that was previously recorded. This adjusts our Omega-3 business to its estimated fair value less cost to sell as a result of the definitive agreement to sell EPAX to Pelagia, signed on June 22, 2017. Refer to Note 10 to the condensed consolidated financial statements included within this Form 10-Q for further information.
Six months ended June 30, 2017 vs. 2016
Discontinued operations, net of income taxes represented a loss of $142.2 million for the six months ended June 30, 2017, compared to income of $42.9 million for the six months ended June 30, 2016. The results for the six months ended June 30, 2017 include an impairment charge of approximately $171 million ($151 million, net of tax) to write down our Omega-3 business to its estimated fair value less cost to sell. Refer to Note 10 to the condensed consolidated financial statements included within this Form 10-Q for further information.
Net income (loss) attributable to FMC stockholders
Three months ended June 30, 2017 vs. 2016
Net income attributable to FMC stockholders increased to a gain of $74.7 million from $65.2 million in the prior-year quarter. The increase was primarily due to a lower effective tax rate, as well as a higher gain from discontinued operations, net of income taxes as discussed above.
Six months ended June 30, 2017 vs. 2016
Net income attributable to FMC stockholders decreased to a loss of $49.5 million from income of $113.5 million in the prior-year quarter. The decrease was primarily due to the impairment charge, associated with our Omega-3 business, which was recorded to discontinued operations as discussed above.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents at June 30, 2017 and December 31, 2016, were $113.2 million and $64.2 million, respectively. Of the cash and cash equivalents balance at June 30, 2017, $92.3 million were held by our foreign subsidiaries. Our intent is to reinvest indefinitely the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings, however, in the first quarter of 2017 we changed our assertion on unremitted earnings for certain foreign subsidiaries as a result of our expected sale of our discontinued FMC Health and Nutrition segment and have recorded the taxes that would be payable upon such repatriation within discontinued operations.
At June 30, 2017, we had total debt of $1,784.8 million as compared to $1,893.0 million at December 31, 2016. Total debt included $1,592.3 million and $1,798.8 million of long-term debt (excluding current portions of $101.2 million and $2.4 million) at June 30, 2017 and December 31, 2016, respectively. As of June 30, 2017, we were in compliance with all of our debt covenants. See Note 9 in the condensed consolidated financial statements included in this Form 10-Q for further details.
Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, increased from $94.2 million at December 31, 2016 to $192.5 million at June 30, 2017.
Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. We had no borrowings under the commercial paper program as of June 30, 2017.
On March 27, 2017, we entered into a commitment letter, that provided for a $1.5 billion 364-day bridge term loan and, in certain circumstances, a $1.5 billion revolving credit facility and a $750 million term loan facility in connection with the Transaction Agreement with DuPont. The proceeds would have been used to finance the acquisition associated with the Transaction Agreement as well as to pay fees and expenses and taxes incurred in connection with the acquisition and the other expected transactions contemplated by or related to the acquisition. On May 2, 2017, the financing available under the Commitment Letter was terminated and replaced by a $1.5 billion term loan facility and an amended and restated $1.5 billion revolving credit facility which is discussed in further detail below.
Term Loan Facility
On May 2, 2017, we entered into a term loan agreement (the “Term Loan Agreement”), that provides for a senior unsecured term loan facility of up to $1.5 billion (the “New Term Loan Facility” or "2017 Term Loan Facility") to fund the expected transaction with DuPont. The New Term Loan Facility is a senior unsecured obligation that ranks equally with our other senior unsecured obligations. The proceeds of the loans to be made pursuant to the New Term Loan Facility will be available in one or more drawings on the closing date of the New Term Loan Facility, which will be substantially concurrent with the closing of the expected transaction with DuPont. The scheduled maturity of the New Term Loan Facility is on the fifth anniversary of this closing date. The proceeds will be used to finance the expected transaction as well as to pay fees, expenses and taxes incurred in connection with the expected transaction and the other expected transactions contemplated by or related to the expected transaction with DuPont or the New Term Loan Facility.
Loans under the Term Loan Agreement will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus in each case an applicable margin, as determined in accordance with the provisions of the Term Loan Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus 1/2 of 1 percent; and the Eurocurrency rate for a one-month period plus 1 percent.
We are required to pay a commitment fee on the average daily unused amount from May 2, 2017 until the date on which all commitments are terminated, payable quarterly, at a rate per annum equal to an applicable percentage in effect from time to time for commitment fees. The initial commitment fee is 0.15 percent per annum. The applicable margin and the commitment fee are subject to adjustment as provided in the New Term Loan Agreement.
The New Term Loan Agreement contains customary financial and other covenants, including a maximum leverage ratio and minimum interest coverage ratio. Fees incurred to secure the New Term Loan Facility have been deferred and will be amortized over the term of the arrangement.
On May 2, 2017, we amended our existing 2014 Term Loan Facility. Among other things, the amendment temporarily increased the maximum leverage ratio financial covenant in order to permit the debt incurred under the contemplated New Term Loan Facility discussed above along with certain other changes to permit the expected transaction with DuPont.
Revolving Credit Facility
On May 2, 2017, we entered into an amended and restated credit agreement (the "Revolving Credit Agreement"). The unsecured Revolving Credit Agreement provides for a $1.5 billion revolving credit facility, with an option, subject to certain conditions and limitations, to increase the aggregate amount of the revolving credit commitments to $2.25 billion (the "Revolving Credit Facility"). The current termination date of the Revolving Credit Facility is May 2, 2022.
Revolving loans under the Revolving Credit Facility will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus, in each case, an applicable margin, as determined in accordance with the provisions of the Revolving Credit Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus 1/2 of 1 percent; and the Eurocurrency rate for a one-month period plus 1 percent. We are also required to pay a facility fee on the average daily amount (whether used or unused) at a rate per annum equal to an applicable percentage in effect from time to time for the facility fee, as determined in accordance with the provisions of the Revolving Credit Agreement. The initial facility fee is 0.15 percent per annum. The applicable margin and the facility fee are subject to adjustment as provided in the Revolving Credit Agreement.
The Revolving Credit Agreement contains customary financial and other covenants, including a maximum leverage ratio and minimum interest coverage ratio. The financial covenant levels have been amended in order to permit the debt incurred under the contemplated New Term Loan Facility discussed above along with certain other changes to permit the expected transaction with DuPont.
Fees incurred to secure the Revolving Credit Facility have been deferred and will be amortized over the term of the arrangement.
Statement of Cash Flows
Cash provided (required) by operating activities of continuing operations was $205.0 million and $160.1 million for the six months ended June 30, 2017 and 2016, respectively.
The table below presents the components of net cash provided (required) by operating activities of continuing operations.
(in Millions)
| 2017 | Six Months Ended June 30 | 2016 |
|---|---|---|
| Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $139.1 | $144.7 |
| Corporate special charges and depreciation and amortization (1) | 82.5 | 82.9 |
| Operating income before depreciation and amortization (Non-GAAP) | $221.6 | $227.6 |
| Change in trade receivables, net (2) | 279.3 | 237.9 |
| Change in inventories (3) | (48.6) | (96.3) |
| Change in accounts payable (4) | 102.8 | 24.3 |
| Change in accrued customer rebates (5) | 96.9 | 138.5 |
| Change in advance payments from customers (6) | (234.4) | (244.8) |
| Change in all other operating assets and liabilities (7) | (117.9) | (6.6) |
| Cash basis operating income (Non-GAAP) | $299.7 | $280.6 |
| Restructuring and other spending (8) | (2.7) | (9.9) |
| Environmental spending, continuing, net of recoveries (9) | (15.1) | (11.4) |
| Pension and other postretirement benefit contributions (10) | (27.6) | (24.8) |
| Net interest payments (11) | (34.3) | (29.8) |
| Tax payments, net of refunds (11) | (6.0) | (31.8) |
| Excess tax benefits from share-based compensation | — | (0.4) |
| Acquisition legal and professional fees (12) | (9.0) | (12.4) |
| Cash provided (required) by operating activities of continuing operations | $205.0 | $160.1 |
(1) Represents the sum of corporate special charges and depreciation and amortization.
(2) The change in cash flows related to trade receivables in 2017 was primarily driven by timing of collections. Collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks. During the six months ended June 30, 2017, we collected over $385 million of receivables in Brazil. A significant proportion of the collections in Brazil are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivable balance. Additionally, the six months ended June 30, 2016 benefited from a one-off early collection in North America which did not repeat.
(3) Inventory changes and the seasonal nature of the business within the different hemispheres are adjusted accordingly to take into consideration the change in market conditions primarily in FMC Agricultural Solutions.
(4) The change in cash flows related to accounts payable is primarily driven by the timing of payments made to suppliers and vendors.
(5) These rebates are associated with our FMC Agricultural Solutions segment in North America and Brazil and generally settle in the fourth quarter of each year. The changes year over year are primarily associated with the mix in sales eligible for rebates and incentives in 2017 compared to 2016 and timing of rebate payments.
(6) Advanced payments are primarily associated with our FMC Agricultural Solutions business within North America and these payments are received in the fourth quarter of each year and recorded as deferred revenue on the balance sheet at December 31. Revenue associated with advance payments is recognized, generally in the first quarter of each year, as shipments are made and title, ownership and risk of loss pass to the customer.
(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to vendors under our vendor finance program.
(8) See Note 8 in our consolidated financial statements included in this Form 10-Q for further details.
(9) Included in the period presented are environmental charges for environmental remediation at our operating sites of $5.6 million and $9.1 million, respectively. The amounts in 2017 will be spent in future years. The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.
(10) There were $24.0 million in voluntary contributions to our U.S. defined benefit plans in 2017 and $21.0 million in 2016.
(11) Amounts shown in the chart represent net payments of our continuing operations. Net interest payments of $10.4 million and $9.4 million and tax payments, net of refunds of $7.9 million and $5.9 million were allocated to discontinued operations for the six months ended June 30, 2017 and 2016, respectively.
(12) 2017 activity represents payments for legal and professional fees associated with the previously announced acquisition of certain assets relating to DuPont's Crop Protection business. 2016 activity represents payments for legal and professional fees associated with the Cheminova acquisition. See Note 3 to the condensed consolidated financial statements included in this Form 10-Q for more information.
Cash provided (required) by operating activities of discontinued operations was $55.1 million and $64.4 million for the six months ended June 30, 2017 and 2016, respectively.
Cash provided (required) by operating activities of discontinued operation is directly related to environmental, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. Amounts also include operating activities related to our discontinued FMC Health and Nutrition segment.
Cash provided (required) by investing activities of continuing operations was $(51.2) million and $(45.0) million for the six months ended June 30, 2017 and 2016, respectively.
The increase in cash required during the six months ended June 30, 2017, as compared to the same period in 2016 was due to payments related to a license and collaboration agreement to obtain certain technology and intellectual property rights as well as a prepayment to Nemaska under a long term supply agreement for lithium carbonate and expenditures related to the expansion of our lithium hydroxide and de-bottlenecking of our carbonate operations.
Cash provided (required) by investing activities of discontinued operations was $(12.8) million and $(14.7) million for the six months ended June 30, 2017 and June 30, 2016.
Cash required by investing activities of discontinued operations is directly associated with the capital expenditures of FMC Health and Nutrition.
Cash provided (required) by financing activities was $(149.8) million and $(151.1) million for the six months ended June 30, 2017 and 2016, respectively.
The change period over period in financing activities is primarily due to the decreases in short term debt payments and proceeds of long term debt, offset by increases in repayments of long term debt in the six months ended June 30, 2017.
Other potential liquidity needs
On March 31, 2017, we signed a definitive agreement to sell FMC Health and Nutrition as part of a larger Transaction Agreement with DuPont. We expect the sale to be completed in the fourth quarter of 2017, subject to customary regulatory approvals and closing conditions. As part of the Transaction Agreement, we will pay DuPont $1.2 billion in cash (subject to certain adjustments set forth in the Transaction Agreement), which reflects the difference in negotiated value between the divested businesses.
Our cash needs outside of the DuPont crop protection acquisition and related integration expenses for 2017 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At June 30, 2017, our remaining borrowing capacity under our credit facility was $1,364.3 million (which includes borrowings under our commercial paper program).
Projected 2017 capital expenditures as well as expenditures related to contract manufacturers are expected to be higher than 2016 levels.
Projected 2017 spending includes approximately $50 million to $55 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.
In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we expect to make voluntary cash contributions of approximately $40 million during 2017. These expected contributions are in excess of the minimum requirements. We contributed $24 million in the second quarter of 2017. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.
For both the six months ended June 30, 2017 and 2016, we paid $44.3 million in dividends declared. On July 20, 2017, we paid dividends totaling $22.2 million to our shareholders of record as of June 30, 2017. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of June 30, 2017.
During the six months ended June 30, 2017, no shares were repurchased under the publicly announced repurchase program. At June 30, 2017, $238.8 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.
Commitments and Contingencies
See Note 17 to the condensed consolidated financial statements included in this Form 10-Q.
Contractual Commitments
Information related to our contractual commitments at December 31, 2016 can be found in a table included within Part II, Item 7 of our 2016 Form 10-K. There have been no significant changes to our contractual commitments during the six months ended June 30, 2017.
Climate Change
A detailed discussion related to climate change can be found in Part II, Item 7 of our 2016 Form 10-K.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Fair-Value Measurements
See Note 16 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.
DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS
Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.
The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.
At June 30, 2017, our financial instrument position was a net asset of $0.4 million compared to a net liability of $2.5 million at December 31, 2016. The change in the net financial instrument position was primarily due to change in exchange rates.
Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.
Commodity Price Risk
Energy costs are diversified among electricity and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and electricity. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at June 30, 2017 and December 31, 2016, with all other variables (including interest rates) held constant.
(in Millions)
| Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease | |
|---|---|---|---|
| Net asset (liability) position at June 30, 2017 | $(0.1) | $0.4 | $(0.6) |
| Net asset (liability) position at December 31, 2016 | $2.0 | $3.3 | $0.8 |
Foreign Currency Exchange Rate Risk
The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the Euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.
To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at June 30, 2017 and December 31, 2016, with all other variables (including interest rates) held constant.
(in Millions)
| Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged Currency vs. Functional Currency 10% Strengthening | 10% Weakening | |
|---|---|---|---|
| Net asset (liability) position at June 30, 2017 | $0.5 | $19.4 | $(18.4) |
| Net asset (liability) position at December 31, 2016 | $(4.5) | $31.9 | $(39.0) |
Interest Rate Risk
One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of June 30, 2017 and December 31, 2016, we had no interest rate swap agreements.
Our debt portfolio, at June 30, 2017, is composed of 68 percent fixed-rate debt and 32 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Term Loan Facility, Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.
Based on the variable-rate debt in our debt portfolio at June 30, 2017, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $2.9 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $2.9 million for the six months of June 30, 2017.
Market risk
As filed, 207 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Controls and procedures
As filed, 3,518 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2017, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended June 30, 2017, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
FMC Corporation:
We have reviewed the accompanying condensed consolidated balance sheet of FMC Corporation and subsidiaries as of June 30, 2017, the related condensed consolidated statements of income (loss) and comprehensive income (loss), for the three‑month and six-month periods ended June 30, 2017 and 2016, and the related condensed consolidated statements of cash flows for the six-month periods ended June 30, 2017 and 2016. These condensed consolidated financial statements are the responsibility of the Company’s management.
We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our review, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2016, and the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2017, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2016, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
/s/ KPMG LLP
Philadelphia, Pennsylvania
August 2, 2017
Risk factors
As filed, 4,612 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2016 Form 10-K as well as in the section captioned “Forward-Looking Information” in our Current Report on Form 8-K filed with the SEC on April 4, 2017 (the “April 4, 2017 Form 8-K”). The risks described in our Form 10-K and the April 4, 2017 Form 8-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.
Forward-Looking Information
Certain statements contained in this communication may constitute “forward-looking statements” and provide other than historical information. In some cases, we have identified forward-looking statements by such words or phrases as “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the proposed transaction and the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. The factors that could cause actual results to differ materially include the following: uncertainties as to the timing of the proposed transaction; the possibility that the parties may be unable to achieve expected synergies and operating efficiencies within the expected time-frames or at all and to successfully integrate the Divested Ag Business into the Company’s Agricultural Solutions business, or the Acquired H&N Business into DuPont’s Nutrition & Health business; such integrations may be more difficult, time-consuming or costly than expected; revenues following the proposed transaction may be lower than expected; operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers) may be greater than expected following the announcement of the proposed transaction; the retention of certain key employees; risks associated with the disruption of management’s attention from ongoing business operations due to the proposed transaction; the conditions to the completion of the transaction may not be satisfied on the anticipated terms and timing or at all, or the regulatory approvals required for the transaction may not be obtained on the terms expected or on the anticipated schedule; the risk that required regulatory approvals and other conditions for the closing of the pending merger of DuPont and The Dow Chemical Company are not received or satisfied or that the merger does not close; the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction; the risk that financing intended to fund the proposed transaction is not obtained, or is obtained on terms other than those previously agreed to; the impact of indebtedness that will be incurred by the Company in connection with the transaction and the potential impact on the rating of indebtedness of the Company; and any other effects of proposed transaction on the Company, including those of the Company’s future financial condition, operating results, strategy and plans; and other factors detailed in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended December 31, 2016 and the Company’s other filings with the SEC, which are available at http://www.sec.gov and on the Company’s website at www.fmc.com (http://www.fmc.com). The Company assumes no obligation to update the information in this communication, except as otherwise required by securities and other applicable laws. We wish to caution readers not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date made.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 6 months2017-01-01 to 2017-06-30 | $1.25bn | us-gaap:Revenues |
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $422.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $802.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $234.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $450.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-04-01 to 2017-06-30 | $126.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2017-01-01 to 2017-06-30 | $236.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $69.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $139.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-04-01 to 2017-06-30 | $3.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $12.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | $74.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | −$49.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $0.56 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | −$0.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $0.56 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | −$0.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 135,603,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 135,328,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | $205.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $20.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2017-01-01 to 2017-06-30 | $44.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2017-06-30 | $113.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $3.49bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $5.98bn | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $1.54bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2017-06-30 | $1.59bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $101.2m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2017-06-30 | $91.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-06-30 | $2.01bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2017-06-30 | 134,128,392 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000037785-17-000048. Last ingested by Listed: Nov 13, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.